Literature DB >> 32624909

Graphene oxide/silver nanohybrid: Optimization, antibacterial activity and its impregnation on bacterial cellulose as a potential wound dressing based on GO-Ag nanocomposite-coated BC.

Javad Mohammadnejad1, Fatemeh Yazdian1, Meisam Omidi2, Arash Darzian Rostami1, Behnam Rasekh3, Atena Fathinia1.   

Abstract

Recently, bacterial cellulose (BC) based wound dressing have raised significant interests in medical fields. However, to our best knowledge, it is apparent that the BC itself has no antibacterial activity. In this study, we optimized graphene oxide-silver (GO-Ag) nanohybrid synthesis using Response Surface Methodology and impregnate it to BC and carefully investigate their antibacterial activities against both the Gram-negative bacteria Escherichia coli and the Gram-positive bacteria Staphylococcus aureus. We discover that, compared to silver nanoparticles, GO-Ag nanohybrid with an optimal GO suspension's pH and [ G O ] [ A g N O 3 ] ratio is much more effective and shows synergistically enhanced, strong antibacterial activities at rather low dose. The GO-Ag nanohybrid is more toxic to E. coli than that to S. aureus. The antibacterial and mechanical properties of BC/GO-Ag composite are further investigated.
© 2018 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Antibacterial effects; Bacterial cellulose; Graphene oxide/Silver nanohybrid; Nanocomposite; Wound dressing

Year:  2018        PMID: 32624909      PMCID: PMC6999449          DOI: 10.1002/elsc.201700138

Source DB:  PubMed          Journal:  Eng Life Sci        ISSN: 1618-0240            Impact factor:   2.678


  2 in total

Review 1.  Latest Advances on Bacterial Cellulose-Based Antibacterial Materials as Wound Dressings.

Authors:  Lu Zheng; Shanshan Li; Jiwen Luo; Xiaoying Wang
Journal:  Front Bioeng Biotechnol       Date:  2020-11-23

Review 2.  Nanocellulose Hybrids with Metal Oxides Nanoparticles for Biomedical Applications.

Authors:  Madalina Oprea; Denis Mihaela Panaitescu
Journal:  Molecules       Date:  2020-09-04       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.